Institute of Medicinal Molecular Design (IMMD), Inc. announced today that the U.S. Food and Drug Administration (FDA) has licensed IMMD's KeyMolnet, the next-generation bioinformatics platform. FDA and IMMD have also agreed to integrate KeyMolnet with the FDA's ArrayTrack system for reviewing pharmacogenomic data submissions.
